Advice on what this means?
Hello! I'm here on behalf of my mother. We just received the latest PET scan after her second round of treatment. Here what it is...
- Interval near complete resolution of multiple lymph nodes below
the diaphragm including periportal, mesenteric, and retroperitoneal
lymphadenopathy, with now FDG uptake almost equal to liver,
consistent with favorable treatment response. Marked decrease in FDG
uptake in the left supraclavicular lymph node.
- Mass adjacent to the gallbladder with interval decrease in size
and avidity, however with some residual hypermetabolism. Given
positive treatment response of multiple lymph node stations to
current treatment, it is difficult to differentiate whether this
hypermetabolism is secondary to infection or inflammation given
recent cholecystostomy tube placement or residual disease."
We discussed that these results are encouraging and allow for delay in future chemotherapy cycles at this time while allowing for improvement in her functional status including nutritional support. Hopefully this will lead to improvement in her sensory and motor neuropathy.
Her case with discussed with HBP surgery who opts against palliative cholecystectomy for disease consolidation. We discussed our recommendation to have her evaluated by radiation oncology for potential consolidative radiation to the residual are of FDG-avidity in the gallbladder.
She was open to this plan and we provided continued encouragement and support for her ongoing attempts to increase PO intake.
I . Interval near complete resolution OT multiple lympn noaes oelow tne aiapnragm
including periportal, mesenteric, and retroperitoneal lymphadenopathy, with now
FDG uptake almost equal to liver, consistent with favorable treatment response.
Marked decrease in FDG uptake in the left supraclavicular lymph node. 2. Mass
adjacent to the gallbladder with interval decrease in size and avidity, however with
some residual hypermetabolism. Given positive treatment response of multiple
lymph node stations to current treatment, it is di#icult to differentiate whether this
hypermetabolism is secondary to infection or inflammation given recent
cholecystostomy tube placement or residual disease. 3. New groundglass opacity
in the right upper lobe demonstrating markedly avidity, favoring infectious versus
inflammatory etiology. Recommend follow-up to complete resolution. 4.
Hyperdense nodule in the right abdominal wall soft tissue with mild surrounding
FDG avidity favoring a hematoma. Recommend close attention on follow-up. The radiology attending physician has personally
reviewed this study, and had reviewed and/or edited this written report and agrees
with it.
I'm wondering what everyone's thoughts on this is. I'm assuming it's great news, especially this this is only 2 rounds in. What what does this mean for the long term?